Design, Synthesis and Bioactivities of Phenylamino-Pyrimidine Derivatives as Novel Protein Tyrosine Kinase Inhibitors

Author(s): Xinfu Hong, Xianzhao Kuang, Guohua Ding, Yilin Liu, Jinlin Liu, Yanjin Zhao, Shuxin Li

Journal Name: Letters in Drug Design & Discovery

Volume 8 , Issue 7 , 2011

Become EABM
Become Reviewer

Abstract:

A series of novel phenylamino-pyrimidine derivatives were designed and synthesized as antitumor agent based on the lead compound of Imatinib by application of the principle of bioisosterism, hybridization and structural optimization. The bioactivities of the new target compounds were tested against human KU812 cells in vitro, some target compounds show promising activities and can be considered for further development.

Keywords: Protein tyrosine kinase, Phenylamino-pyrimidine, Synthesis, Bioactivity, Protein kinases, 2-phenylaminopyrimidine, bioisosterism, chronic myelogenous leukemia (CML), HNMR, DMSO-d6, tetramethylsilane (TMS), human KU812 cells, B ring, pharmacophores

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 7
Year: 2011
Page: [596 - 601]
Pages: 6
DOI: 10.2174/157018011796235202
Price: $65

Article Metrics

PDF: 8